(600380)"Joincare Pharmaceutical Group Industry Co., Ltd."Report for Q3 2026
Filed with SSE · Stock code 600380 · · 12 pages · Chinese
Joincare Pharmaceutical Group Industry Co., Ltd. on 6ix
Earlier from Joincare Pharmaceutical Group Industry
- (600380)"Joincare Pharmaceutical Group Industry Co., Ltd."Announcement on Progress in Providing Entrusted Loans to the Controlled Subsidiary Jiaozuo Jianfeng
- (600380)"Joincare Pharmaceutical Group Industry Co., Ltd."Announcement on Implementation of Dividend Distribution for the First Half of 2026
- (600380)"Joincare Pharmaceutical Group Industry Co., Ltd."Announcement on Progress in Providing Guarantees for Controlled Subsidiaries
Later from Joincare Pharmaceutical Group Industry
- (600380)"Joincare Pharmaceutical Group Industry Co., Ltd."Announcement on Obtaining Drug Registration Certificate
- (600380)"Joincare Pharmaceutical Group Industry Co., Ltd."Announcement on Receipt of the Drug Clinical Trial Approval Notice for Recombinant Humanized Anti-FXI Bispecific Antibody Injection
- (600380)"Joincare Pharmaceutical Group Industry Co., Ltd."Announcement on Receipt of the Drug Clinical Trial Approval Notice for Tiange Dingxuan Granules
Follow Joincare Pharmaceutical Group Industry into a list and get an email when it puts out news.
Follow Joincare Pharmaceutical Group Industry